Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences

Area of Science:

• Cardiovascular Medicine
• Gastroenterology
• Immunology

Background:

• Patients with inflammatory bowel disease (IBD) exhibit an elevated risk of cardiovascular disease (CVD), including myocardial infarction and stroke.
• CVD in IBD patients often presents at a younger age and is associated with active disease, diverging from traditional CVD risk profiles.
• Both IBD and atherosclerotic CVD (ASCVD) are characterized by chronic inflammation, suggesting a shared inflammatory pathway driving ASCVD risk in IBD.

Purpose of the Study:

• To discuss the causes of cardiovascular disease (CVD) in patients with inflammatory bowel disease (IBD).
• To explore potential strategies for modifying the consequences of CVD in IBD patients.
• To highlight the need for specific guidelines and risk assessment tools for ASCVD in IBD.

Main Methods:

• Literature review and synthesis of existing research on IBD and CVD.
• Analysis of the role of chronic inflammation in the development of ASCVD in IBD patients.
• Discussion of the impact of IBD medications on ASCVD risk.

Main Results:

• Chronic inflammation in IBD is a significant factor contributing to increased ASCVD risk.
• IBD medications can have variable effects, either increasing or decreasing ASCVD risk.
• Current guidelines and assessment methods for ASCVD are lacking for IBD patients.

Conclusions:

• Inflammatory bowel disease significantly increases cardiovascular disease risk, particularly in younger patients with active disease.
• Targeting inflammation may be a viable strategy to mitigate ASCVD risk in IBD, though further data are required.
• Development of specific guidelines for ASCVD risk assessment and management in IBD is crucial.